Testing a clot removal device for deep vein thrombosis in the leg
Tests a device that removes blood clots in adults with leg deep vein thrombosis.
Key facts
- Who runs it
- BrosMed Medical Co., Ltd
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Clinical Trial of Thrombectomy Systems
- Status
- Recruiting
- People taking part
- 167 people, planned
- Started
- 30 Aug 2026
- Expected to end
- 30 Dec 2027
- Type of study
- Interventional
- Treatments tested
- Peripheral thrombectomy system
- Record updated
- 7 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a blood clot in a deep vein of the leg (DVT), confirmed by imaging. It tests a device that removes the clot.
- Age
- 18 years and older
- Sex
- All sexes can join
- Disease stage
- Acute clot in the iliofemoral or femoropopliteal veins, or subacute clot in the iliofemoral veins. Expected to live at least 1 year.
- Earlier treatment
- People whose clot came back after an earlier procedure on the same spot cannot join. People with a stent already in the target vein cannot join.
Main reasons for not taking part
- Clots in both legs that need removal in the same procedure
- Unstable blood clot in the lungs (pulmonary embolism)
- Active bleeding or a stroke within the past 30 days
- Severe bleeding or clotting disorder, or severe liver or kidney problems
- Pregnant or breastfeeding, or planning a pregnancy during the study
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Age ≥18 years;
- Confirmed lower extremity deep vein thrombosis (DVT) by imaging, meeting at least one of the following: (1) acute iliofemoral or femoropopliteal DVT; or (2) subacute iliofemoral DVT
- Investigator-assessed life expectancy ≥1 year
- Willing to participate in this study and provide written informed consent
Who cannot take part
- The target lesion thrombosis is recurrent after prior interventional therapy
- Currently participating in any other clinical trial of a drug or medical device
- Infection at the puncture site or severe systemic infection
- Bilateral lower extremity deep vein thrombosis requiring thrombectomy in the same procedure
- Active bleeding within the past 30 days, including severe intracranial, gastrointestinal, or urinary tract bleeding
- History of hemorrhagic or ischemic stroke within the past 30 days
- Known severe coagulation disorder or bleeding tendency
- Severe hepatic or renal impairment
- Known allergy or significant hypersensitivity to iodine-based contrast media, thrombolytic agents, anticoagulants, or antiplatelet drugs
- Known conditions such as severe hyperthyroidism, multiple myeloma, or severe heart failure that preclude tolerance to percutaneous transluminal angioplasty
- Any other condition that, in the investigator's judgment, makes the subject ineligible for participation in this trial
- Inability to establish vascular access or difficulty in advancing the guidewire through the lesion
- Hemodynamically unstable pulmonary embolism
- A venous stent has been implanted in the target lesion, or the presence of an inferior vena cava filter that interferes with device deployment
- Pregnant or lactating women, or women planning to become pregnant during the study period
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study plans to enroll 167 subjects. Subject enrollment and treatment details will be documented, and follow-up assessments will be conducted at screening, on the procedure day, before discharge, and at 1, 3, and 6 months after the procedure, to assess the safety and efficacy of the peripheral thrombectomy system for the treatment of lower extremity deep vein thrombosis.
The group in the trial
- Test groupTreatment being tested
Thrombectomy system
Treatment: Peripheral thrombectomy system
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Multicenter, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Thrombectomy Systems for the Treatment of Lower Extremity Deep Vein Thrombosis
- Plain-language title
- Testing a clot removal device for deep vein thrombosis in the legGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 7 August 2026